XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue (Tables)
 3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]
The following table represents our revenues disaggregated by product line (in thousands):

Three months ended
March 31,
Product line20242023
Consumables$244,039 $236,122 
Infusion Systems157,338 161,713 
Vital Care165,278 170,814 
Total Revenues$566,655 $568,649 

For the three months ended March 31, 2024 and 2023, net sales to Medline made up approximately 17% and 15% of total revenues, respectively.

The following table represents our revenues disaggregated by geography (in thousands):
Three months ended
March 31,
Geography20242023
United States$366,155 $359,187 
Europe, the Middle East and Africa98,389 98,986 
APAC51,853 58,624 
Other Foreign50,258 51,852 
Total Revenues$566,655 $568,649 
Contract with Customer, Asset and Liability [Table Text Block] The following table presents the changes in our contract balances for the three months ended March 31, 2024 and 2023 (in thousands):
Contract Liabilities
Beginning balance, January 1, 2024$(42,177)
Equipment revenue recognized7,499 
Equipment revenue deferred due to implementation(9,340)
Software revenue recognized4,677 
Software revenue deferred due to implementation(5,571)
Government grant income recognized(1)
515 
Government grant income deferred— 
Other deferred revenue(155)
Other deferred revenue recognized1,195 
Ending balance, March 31, 2024
$(43,357)
Beginning balance, January 1, 2023$(45,866)
Equipment revenue recognized5,976 
Equipment revenue deferred due to implementation(7,236)
Software revenue recognized4,108 
Software revenue deferred due to implementation(5,362)
Government grant income deferred(861)
Government grant income recognized(1)
218 
Other deferred revenue(403)
Other deferred revenue recognized1,915 
Ending balance, March 31, 2023
$(47,511)
Deferred Revenue, by Arrangement, Disclosure
As of March 31, 2024, revenue from remaining performance obligations is as follows:

Recognition Timing
(in millions)< 12 Months> 12 Months
Equipment deferred revenue$(20,007)$(890)
Software deferred revenue(9,923)(512)
Government grant deferred income(1)
(2,064)(8,900)
Other deferred revenue(2)
(758)(303)
Total $(32,752)$(10,605)
_________________________________
(1) The government grant deferred income is amortized over the life of the related depreciable asset as a reduction to depreciation expense.
(2) Other deferred revenue includes pump development programs, purchased training and extended warranty.